Parmax Pharma has informed that it enclosed the Compliance Certificate for the year ended on 31st March, 2025, certifying that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent, Purva Sharegistry (India).
The above information is a part of company’s filings submitted to BSE.